LifeStance Health Group

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

LifeStance Health Group reports strong Q4 performance and outlines growth strategies for 2023

LifeStance Health Group's Q4 2022 performance reflects financial stability and operational strength, meeting expectations.
The company's strategic focus on long-term profitability, clinician growth, and value-based care positions it for future success.
Challenges include consolidation efforts, payer contracting complexities, and transitioning to an integrated care model.
Opportunities for growth lie in collaboration with physical care providers, value-based care models, and data-driven approaches.

LifeStance Health Group exceeds Q1 expectations, eyes sustainable growth

LifeStance Health Group's Q1 2023 performance showcased strong financial results and operational advancements, driven by clinician growth and strategic initiatives.
While facing challenges such as clinician recruitment and margin progression, the company's focus on retention and value-based care initiatives bodes well for future growth.
With opportunities in clinician expansion, operational enhancements, and market adaptation, LifeStance Health Group is poised to capitalize on emerging trends and drive sustainable success.

LifeStance Health Group excels in Q2, eyes growth opportunities

LifeStance Health Group's Q2 2023 earnings call highlighted strong financial performance, operational improvements, and a strategic focus on enhancing patient care and value-based care arrangements. The company is navigating challenges in streamlining operations and adapting to regulatory changes while capitalizing on opportunities to drive growth and operational efficiencies.

LifeStance Health Group exceeds Q3 expectations, focuses on growth

LifeStance Health Group's Q3 2023 performance reflects strong revenue growth, operational improvements, and a focus on patient and clinician satisfaction.
While facing challenges such as negative free cash flow and ongoing legal actions, the company is poised for growth through revenue guidance increases and strategic investments.
Opportunities for revenue growth, clinician expansion, and enhanced patient experiences align with the company's commitment to quality care and financial performance.
CEO Ken Burdick's emphasis on exceeding expectations, raising guidance, and navigating legal challenges underscores the company's resilience and strategic direction.

LifeStance Health Group beats 2023 metrics, focuses on growth optimization

LifeStance Health Group's strong financial performance in 2023 reflects a focus on profitability, clinician growth, and patient experience, with plans for continued optimization.
Strategic investments in technology and operational processes position the company for future success, while challenges in moderating growth and improving funnel efficiency require attention.
Opportunities lie in enhancing patient acquisition and retention, clinician productivity, and operational efficiency, leveraging the company's early growth stage for scalability.
Management's commitment to a purpose-driven culture and operational excellence, supported by a dedicated team, underpins LifeStance Health Group's path to sustained success.

LifeStance Health Group excels in Q1 2024, eyes growth opportunities

LifeStance Health Group's Q1 2024 Earnings Call showcased robust financial performance, strategic resilience, and a focus on growth. While facing leadership transitions and short-term challenges, the company is poised for positive cash flow and continued improvements in revenue and margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SCOTTSDALE, Ariz., March 10, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced financial results for the fourth quarter and full year ended December 31, 2021.

LifeStance Reports Fourth Quarter and Full Year 2021 Results

SCOTTSDALE, Ariz., Feb. 17, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter earnings release after the market closes on Thursday, March 10, 2022.

LifeStance to Host Fourth Quarter and Full Year 2021 Earnings Conference Call on March 10, 2022

SCOTTSDALE, Ariz., Jan. 03, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 40th Annual J.P. Morgan Healthcare Conference, which will be hosted virtually.

LifeStance to Participate in the 40th Annual J.P. Morgan Healthcare Conference

Atlanta, Georgia--(Newsfile Corp. - December 15, 2021) -  Holzer & Holzer, LLC continues to investigate whether LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST) complied with federal securities laws. On August 11, 2021, LifeStance, one of the largest providers of mental healthcare in the United States, announced financial results for the second quarter, reporting a $70 million net loss. LifeStance also provided disappointing estimates for the third quarter, which was below...

SHAREHOLDER ALERT: Ongoing Investigation of LifeStance Health Group, Inc. by Holzer & Holzer, LLC

SCOTTSDALE, Ariz., Dec. 1, 2021 /PRNewswire/ --  LifeStance Health  (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced it has been Certified™ by Great Place to Work®, the global authority on workplace culture, employee experience and leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation.

LifeStance Health Earns 2021 Great Place To Work Certification™

SCOTTSDALE, Ariz., Nov. 22, 2021 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will participate in a fireside chat at the upcoming Evercore ISI 4th Annual HealthCONx Conference, which is being hosted virtually.

LifeStance to Participate in Evercore ISI 4th Annual HealthCONx Conference

NEW YORK--(BUSINESS WIRE)-- #LifeStance--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against LifeStance Health Group (“LifeStance” or the “Company”) (NASDAQ: LFST) on behalf of LifeStance stockholders. Our investigation concerns whether LifeStance has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. LifeStance is one of the nation's largest providers of

LIFESTANCE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeStance Health Group, Inc. on Behalf of LifeStance Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)---- $LFST--The law firm of Kirby McInerney LLP is investigating potential claims against LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST). The investigation concerns whether LifeStance has violated the federal securities laws and/or engaged in other unlawful business practices. LifeStance is one of the nation's largest providers of virtual and in-person outpatient mental health care for children, adolescents, and adults experiencing a variety of menta

INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of LifeStance Health Group, Inc. (LFST) Investors

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces an investigation into potential violations of U.S. federal securities laws by LifeStance Health Group, Inc. (NASDAQ: LFST) focused on whether LifeStance Health and certain of its officers and directors, as well as the underwriters of LifeStance Health's June 2021 initial public offering, made false and misleading statements and/or failed to disclose material information to investors. If you have information that could as

LFST INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into LifeStance Health Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your LifeStance investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you ca

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of LifeStance Health Group, Inc. (LFST) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $LFST #investors--The Law Offices of Frank R. Cruz Continues Its Investigation of LifeStance Health Group, Inc. (LFST) on Behalf of Investors

The Law Offices of Frank R. Cruz Continues Its Investigation of LifeStance Health Group, Inc. (LFST) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) investors concerning the Company's possible violations of federal securities laws. In June 2021, LifeStance completed its initial public offering (“IPO”), issuing 32.8 million shares at $18 per share. On August 11, 2021, LifeStance announced its second quarter 2021 financial results, reporting a net loss of $70 milli

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of LifeStance Health Group, Inc. (LFST) on Behalf of Investors

The company whiffed big on its third-quarter earnings as operating expenses continued to rise steeply.

Why LifeStance Health Group Fell 24% on Tuesday

LifeStance Health Group, Inc. (LFST) CEO Michael Lester on Q3 2021 Results - Earnings Call Transcript

Third Quarter 2021 Highlights (All results compared to prior-year comparative period, unless otherwise noted)

LifeStance Reports Third Quarter 2021 Results

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In LifeStance To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - November 5, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST).If you suffered losses exceeding $50,000 investing in LifeStance stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional...

Lifestance Shareholder Alert

Lifeist Wellness Inc. (TSXV:LFST) (FRANKFURT: M5B) (OTC:NXTTF), formerly known as Namaste Technologies Inc., announced Thursday that its portfolio business and wholly-owned subsidiary CannMart Labs Inc. has successfully produced its first manufactured products under the 2.0 consumer-focused house brand “Roilty” and has begun commercialization. The move is a key part of Labs' strategy to introduce a larger portfolio of higher-margin cannabis 2.0 products into the Canadian market as part of Lifeist's transition to profitable growth.

Lifeist Wellness' CannMart Labs Kicks Off Commercialization Of House Brands

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In LifeStance To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - November 3, 2021) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST).If you suffered losses exceeding $50,000 investing in LifeStance stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional...

LifeStance Investor Alert

SCOTTSDALE, Ariz., Nov. 03, 2021 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will participate in a virtual fireside chat with Jefferies equity research analyst Stephanie Wissink, as well as individual investor meetings.

LifeStance Health to Participate in Virtual Fireside Chat and Investor Meetings with Jefferies

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In LifeStance To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 29, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST).If you suffered losses exceeding $50,000 investing in LifeStance stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for...

Lifetance Shareholder Alert

SAN DIEGO, Oct. 28, 2021 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against LifeStance Health Group, Inc. (NASDAQ: LFST) ("LifeStance " or the "Company") for violations of federal securities laws. On Wednesday, August 11, 2021, LifeStance released its second quarter ended June 30, 2021, financial results, reporting a net loss of $70 million.

(LFST) Alert: Did You Lose Money on Your LifeStance Investment? Contact Johnson Fistel Regarding Investigation

SCOTTSDALE, Ariz., Oct. 27, 2021 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will participate in a fireside chat at the upcoming Credit Suisse 30th Annual Healthcare Conference, which is being hosted virtually.

LifeStance Health to Participate in the Credit Suisse 30th Annual Healthcare Conference

SCOTTSDALE, Ariz., Oct. 18, 2021 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter earnings release after the market closes on Monday, November 8, 2021.

LifeStance Health to Host Third Quarter 2021 Earnings Conference Call on November 8, 2021

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In LifeStance To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 10, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST).If you suffered losses exceeding $50,000 investing in LifeStance stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional...

Lifestance Update

San Francisco, California--(Newsfile Corp. - September 28, 2021) -  Hagens Berman urges LifeStance Health Group, Inc. (NASDAQ: LFST) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.Visit: www.hbsslaw.com/investor-fraud/LFST Contact An Attorney Now: LFST@hbsslaw.com 844-916-0895LifeStance Health Group, Inc. (LFST) Investigation: The investigation focuses LifeStance's statements concerning its financial performance

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages LifeStance Health Group (LFST) Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations

News for LifeStance Health Group Stock (LFST)